The 1 analysts offering 12-month price forecasts for Bellicum Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +270.37% increase from the last price of 1.35.
The current consensus among 1 polled investment analysts is to Buy stock in Bellicum Pharmaceuticals Inc. This rating has held steady since February, when it was upgraded from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.13
Reporting Date Aug 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.